Cocrystal Pharma (COCP) Cash from Operations (2010 - 2026)

Cocrystal Pharma (COCP) has 16 years of Cash from Operations data on file, last reported at 2340000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 20.38% year-over-year to 2340000.0; the trailing twelve-month figure through Mar 2026 stood at 7601000.0 (up 49.06% YoY), and the FY2025 full-year result was 8200000.0, up 50.26% from the prior year.
• Cash from Operations eased to 2340000.0 in Q1 2026, from 1744000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1362000.0 in Q3 2025 to a low of 8908000.0 in Q3 2022.
• A 5-year average of 3713294.12 and a median of 3326000.0 in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations tumbled 120.9% in 2022 and soared 73.41% in 2025, its largest moves.
• Tracing COCP's Cash from Operations over 5 years: stood at 4893000.0 in 2022, then surged by 32.03% to 3326000.0 in 2023, then advanced by 4.99% to 3160000.0 in 2024, then soared by 44.81% to 1744000.0 in 2025, then tumbled by 34.17% to 2340000.0 in 2026.
• Business Quant data shows COCP's Cash from Operations at 2340000.0 in Q1 2026, 1744000.0 in Q4 2025, and 1362000.0 in Q3 2025.